“ As a multicultural company, we believe in the future growth of Belgium’s innovative biotechnology sector. It is absolutely a country which should be observed carefully by… ”
In Conversation
“ Without any doubt, my biggest achievement at EastHORN is building a strong team that I can always rely on. Once you have found the perfect team,… ”
“ The complexity of the Belgian market is difficult to change. Progress is being made, but slower than we would like to see ”
“ Merck is well-positioned to be a partner to the authorities in many ways including R&D, production, and technology integration ”
Rostislav Hartman – General Manager, Zimmer Biomet Czech Republic, Slovakia, Romania & Distributor Markets
“ Comparing the Czech Republic with other markets in EE, I would say that the country provides a solid landscape for the introduction of new products and… ”
“ Romania needs to find alternative sources of funding and requires more effective management of the current budget ”
“ I believe Nordic Belgium can be a great role model for other countries on how to successfully leverage a country’s assets to bring new products to… ”
“ Even though the consumption of medicines per capita [in Romania] is still lower than the European average, we are catching up ”
“ Increasingly, medicines are putting pressure on public funds, that is why companies must contribute to facilitating patient access to treatment in accordance with the applicable legislation ”
“ Accord provides one-third of the oncological treatments in Europe which makes it the continent's leading supplier of oncology products. In Romania, oncology and haematology are the… ”
“ Colorectal ... is the second most predominant cancer in the Czech Republic, and an area with a high unmet medical need. Our combo therapy represents a… ”
“ Building a highly skilled labour force in Romania is becoming increasingly difficult due to the ‘brain drain’ phenomenon and a lack of attractiveness in the Romanian… ”